Resolution of Thyroid Acropachy in a Patient Treated With Teprotumumab: A Case Report and Review of Mechanisms
Graves’ disease is an autoimmune thyroidopathy associated with hyperthyroidism and nonendocrine manifestations such as thyroid eye disease (TED), pretibial myxedema, and thyroid acropachy. Thyroid acropachy is an uncommon but debilitating condition, typically characterized by digital clubbing, soft...
Saved in:
| Main Author: | Soumya Chatterjee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Case Reports in Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/crie/5544869 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Update on Medical Management of Thyroid Eye Disease with Insights on Teprotumumab
by: Smriti Dabas, et al.
Published: (2023-07-01) -
Teprotumumab in the management of thyroid eye disease mechanistic insights and adverse reactions: a comprehensive review
by: Zhibin Xu, et al.
Published: (2025-05-01) -
The Efficacy and Safety of Teprotumumab in Thyroid Eye Disease: Evidence from Randomized Controlled Trials
by: Fei Lin, et al.
Published: (2023-01-01) -
Spectral-domain optical coherence tomography imaging findings in patients receiving teprotumumab for thyroid eye disease
by: Timothy Truong, et al.
Published: (2025-06-01) -
A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patientsResearch in context
by: Yuji Hiromatsu, et al.
Published: (2025-02-01)